The Ser/Thr kinase MARK2 phosphorylates tau protein at sites that cause detachment from microtubules in Alzheimer neurofibrillary degeneration. Homologs of MARK2 include Par-1 in C. elegans and Drosophila, which generates embryonic polarity. We report the X-ray structure of the catalytic and ubiquitin-associated domains (UBA) of human MARK2. The activity was altered by mutations in the ATP binding site and/or activation loop. The catalytic domain shows the small and large lobes typical of kinases. The substrate cleft is in an inactive, open conformation in the inactivated and the wild-type structure. The UBA domain is attached via a taut linker to the large lobe of the kinase domain and leans against a hydrophobic patch on the small lobe. The UBA structure is unusual because the orientation of its third helix is inverted, relative to previous structures. Possible implications of the structure for the regulation of kinase activity are discussed.
Introduction
The activity of the protein kinase MARK (MAP microtubule affinity regulating kinase) was initially noticed in the search for pathological phosphorylation sites of tau protein (Biernat et al., 1993) . Tau is a microtubuleassociated protein prominent in the brain, particularly in the axonal compartment of neurons, where it helps to stabilize microtubules. The tau-microtubule interaction is regulated by phosphorylation, especially at the KXGS motifs in the repeat domain of tau which represents the core of the microtubule binding domain. The same domain also forms the core of the abnormal tau aggregates (paired helical filaments; PHF) in Alzheimer's disease. Microtubule binding and PHF assembly are efficiently suppressed when tau is phosphorylated by MARK. Thus, excess activation of MARK in cells leads to microtubule breakdown because they are not properly stabilized. A second function of tau is its interference with motor proteins moving along microtubules; this function is also fine-tuned in axons by MARK (Mandelkow et al., 2004) . Both MARK and tau are important for the establishment of neuronal polarity (Biernat et al., 2002) .
Compared to other kinases, MARK is a large protein (w720-790 amino acids) which contains an N-terminal leader sequence, a kinase catalytic domain, a ubiquitin-associated domain (UBA), a spacer, and a tail domain containing the KA1 (kinase-associated) motif characteristic for the family of kinases ending with the ELKL motif ( Figure 1A ). Four isoforms of MARK (1-4) were found in rats, encoded by different genes, with additional splicing variants (Drewes, 2004; Drewes et al., 1997) . MARK family members show a striking homology to kinases of the Par-1 family, which are best known for their role in defining embryonic polarity in Drosophila and C. elegans (for reviews, see Kemphues, 2000; Tomancak et al., 2000) . Members of the MARK/Par-1 family occur in most organisms examined so far. Analysis of the human genome showed that there are four members of the human MARK family which belong to the class of CaMKII kinases (Manning et al., 2002) . Known targets of MARK family members include tau, MAP2, MAP4, doublecortin, PTPH1, Cdc25C, KSR1, plakophilin, dishevelled, oskar, and Raf1; these proteins are typically involved in the regulation of the cytoskeleton and in signaling (for a review, see Drewes, 2004) .
Like other kinases, MARK family members can be activated by phosphorylation in the ''activation loop'' which controls the access of the substrate to the catalytic center (for reviews, see Huse and Kuriyan, 2002) . This can be achieved by the protein kinase MARKK, which phosphorylates T208 in MARK2 and the corresponding residues in MARK1, 3, and 4 (Timm et al., 2003) . The same kinase was found in the context of activation of MEKs and named TAO-1 (Hutchison et al., 1998) . MARK can also be activated by LKB1, which plays a role in tumor suppression (Lizcano et al., 2004) . A notable feature of MARK isolated from brain tissue is its double phosphorylation in the activation loop (at T208 and S212 in MARK2) (Drewes et al., 1997) . Whereas phosphorylation of T208, the target of MARKK or LKB1, activates the kinase, phosphorylation of S212 is inhibitory (Timm et al., 2003) . A further level of regulation lies in the association with other proteins and domains. In the related kinase KIN1 in yeast, the tail domain motif is thought to bind and inactivate the catalytic domain (Elbert et al., 2005) . MARK in turn phosphorylates other partners which then bind to 14-3-3, such as Cdc25C, KSR1, plakophilin, or Raf-1 (Benton et al., 2002; Muller et al., 2003) . Finally, the presence of a UBA domain adjacent to the catalytic domain suggests potential interactions with proteins involved in the ubiquitin proteosome pathway, DNA repair, or cell signaling (Brajenovic et al., 2004; Hofmann and Bucher, 1996; Mueller and Feigon, 2002) .
Because of the potential importance of MARK in basic physiological processes and human pathology, we embarked on a structural analysis of MARK family members as a step toward identifying interaction sites or inhibitors. Here we report the X-ray structure of the catalytic domain of MARK2, combined with the UBA domain. The catalytic domain shows the typical features expected for an inactive kinase with a disordered activation loop. The UBA domain is tethered to the large lobe via an extended linker comprising a structural motif similar to the common docking domain of the MAPK family that provides an interaction site for upstream or downstream signaling molecules.
Results
The fragment of human MARK2 described here (residues N39-K364) comprises part of the N-terminal header (N39-N52), catalytic domain (Y53-M304), CD motif and linker (N305-D322), and UBA domain (Y323-K362) ( Figures 1A and 1B) . Crystals of the wild-type construct and of two inactive mutants were analyzed, K82R and T208A/S212A. K82 is essential for catalysis, T208 is the primary phosphorylation site in the activation loop, and S212 was also found to be phosphorylated in MARK2 from brain (Drewes et al., 1997) . Phosphorylation of T208 is required for full activation, but phosphorylation of S212 or mutation to alanine completely abolishes the kinase activity of MARK2 (Timm et al., 2003) . Many Ser/Thr kinases have a conserved threonine at position S212 in MARK2 which contributes to substrate specificity and assists in catalysis (Chen et al., 2000; Min et al., 2004; Taylor et al., 1995) . Figure 1C shows that the wild-type construct has a basal kinase activity even without phosphorylation of T208, whereas the activities of the mutants are largely diminished. The three variants and a selenomethionine (SeMet) derivative of the T208A/S212A double mutant crystallized in the hexagonal space group P6 1 . Two similar crystal forms were observed, which differ only by the length of the c axis: c = 106.0 Å for the double mutant, and c = 99.7 Å for the wild-type and the K82R mutant; the wild-type was found in both forms. All crystal structures are similar in crystal packing and folding of the molecules. The general (A) Bar diagram of MARK2 domain structure. Residue numbers refer to the longest isoform of human MARK2 (Swiss-Prot entry Q7KZI7). Phosphorylation of T596 by atypical PKC downregulates membrane localization and kinase activity (Hurov et al., 2004) . The short bar diagram above that of the full-length protein represents the construct used for X-ray structure analysis. The fragment used is identical in rat and human MARK2. (B) Structural sequence comparison of MARK2 and related kinases. Secondary structure is color coded (orange, a helices; pink, 3 10 helices; yellow, b strands) and numbered in the usual kinase convention. Special elements are boxed (P-loop in active site, hinge between lobes, catalytic loop containing RD motif, activation segment with N anchor, P+1 loop, and C anchor, CD domain, UBA domain). Blue residues are not visible due to disorder. (C) Kinase activities of the MARK2 constructs. Relative activities were assayed as described (Drewes et al., 1997 ) using a substrate peptide from the first repeat of tau containing S262 in the KXGS motif (TR1 peptide NVKSKIGSTENLK); data show averages of four experiments (error bars, SEM). structure will be described by reference to the T208A/ S212A mutant, which has the highest resolution.
Catalytic Domain
The crystals contain two molecules per asymmetric unit (C a traces; Figure 2 ). The kinase domain has a bilobed structure like many other kinases. The smaller, N-terminal lobe (residues w53-130; N lobe) consists of five b strands and an a helix (helix C according to cAMPdependent protein kinase; PKA), whereas the C-terminal lobe (residues w135-304; C lobe) is composed mainly of a helices. A structural sequence alignment with other kinases is presented in Figure 1B , including the notation used for the structural elements. The 11 initial residues (G38-P48) are invisible due to disorder. Residues D193-K205 including the DFG motif and most of the activation loop are also disordered. Figure 3A shows details of the electron density map around L206, the first residue following the invisible part of the activation segment. The two lobes are linked by a flexible segment of six amino acids (130-135) including two glycines, G134-G135. Furthermore, H bonds between the lobes Stereoview of an overlay of C a traces of molecules A and B in the asymmetric unit, based on the SeMet double mutant T280A/S212A (A, blue; B, with different colors depending on distance to A, blue to red). The superposition was calculated using residues 135-309 (C lobe). Not shown are residues 38-47, 193-205 (activation (Murshudov et al., 1997) and contoured at 1 s level. The final model is superimposed to the electron density. (A) View of the C-terminal end of the activation segment. Residues L206-S212A were omitted before calculation of the map. The view is perpendicular to the 2-fold NCS axis relating molecules A and B. Close to the center are cysteines C210 of both molecules, which form a disulfide bridge (orange) in the structures of the MARK2 double mutant. (B) View of the C-terminal part of the peptide stretch that links the UBA domain to the catalytic domain. Residues Y316-K324 were omitted before calculation of the map. Although there is virtually no contact to the catalytic domain or to another molecule, the electron density is well defined. The figure was generated with PyMOL (DeLano, 2002). connect residues in the loop between helix C and strand b4 (C lobe) with residues in helix E and the loop between b7 and b8 (N lobe). Both the covalent link and the H bond interactions are restricted to a narrow region at the back of the catalytic cleft and serve as a hinge that allows the small lobe to librate, thereby opening and closing the catalytic cleft.
Conformation of the Activation Loop
Whereas most of the activation loop is disordered in the wild-type and K82R structures (D193-C210), the T208A/ S212A mutant reveals five more residues at the end of the activation loop (L206-C210). This includes the P+1 loop (F209-A217), which is thought to recognize the substrate by specific interaction with the residue following the phosphorylation site. The end of the activation segment (P213-E219 including the APE motif) is well defined in all MARK2 structures. The conformation of the structured parts of the activation segment indicates that it folds away from helix C, in the opposite direction to most active kinases (Nolen et al., 2004) , and occupies the area below the P-loop (Figure 4 ; see Discussion).
Intermolecular Disulfide Bridge
In the double mutant, the end of the activation loop (206-212) is stabilized by an intermolecular disulfide bridge between cysteines C210 of two adjacent molecules that are related by noncrystallographic symmetry (Figure 3A) . C210 is located in the midst of T208A and S212A, the two phosphorylatable sites that distinguish the double mutant from the wild-type. Formation of the disulfide bridge is probably a crystallization artifact. It appears that the S-S bridge is essential for crystallization, as crystals do not form in the presence of dithiothreitol (DTT). This holds for all variants of the protein, although the disulfide bridge is visible only in the T208A/ S212A structure.
Dimerization
The MARK2 crystals contain two molecules per asymmetric unit (A and B) that interact via multiple contacts and form a dimer with a proper 2-fold noncrystallographic symmetry ( Figure 5 ). The catalytic domains in a dimer face each other with their active sites. The most variable and disordered portion of the activation segment is close to the center of the dimer, encircled by and helix C; the P-loop has been omitted to allow an unobstructed view of the invariant ion pair (K82 and E100 in MARK2, K162 and E181 in Aurora-A) that coordinates a-and b-phosphates of the bound nucleotide in the active state (F). In the inactive structures (D and E), the ion pair interaction is disrupted. Part of the catalytic loop around the enzymatically active aspartate (D175 in MARK2, D256 in Aurora-A) and the preceding arginine (R174 in MARK2, R255 in Aurora-A) is represented by its C a trace to show the subtle differences in the conformations of MARK2 and Aurora-A. In the active state (C and F), the arginine of the conserved RD motif is hydrogen bonded to phosphothreonine pT288. the four lobes of the catalytic domains. Interactions between the monomers are concentrated in three zones ( Figure 5 ). Zone 1 in the C lobe and zone 3 in the N lobe of one molecule form a wide-open entrance to the catalytic cleft. Helix G of the other molecule (zone 2) inserts into this space, making contacts to both rims. In the T208A/S212A mutant, 30 residues of each molecule are involved in intradimer contacts, whereas the wild-type and K82R mutant show only 18 contact residues, and the S-S bond at C210 is not visible. Thus, the dimer-forming interaction in these constructs appears to be weakened compared to the double mutant. This could explain the difference in crystal packing between wild-type and double mutants (see Supplemental Data available with this article online).
UBA Domain
The UBA domain (Y323-K362) is a small, globular domain that consists of three short helices (a1-a3). Helices a1 and a3 are roughly antiparallel (folding reminiscent of a ''U''; Figure 6 ). This conformation is unexpected because the helices of other UBA domains solved so far ( Figure 6A ; structural sequence alignment) alternate so that a1 and a3 are almost parallel to each other (as in an ''N''). Figure 6B compares stereoviews of the MARK2 UBA domain (yellow) with the UBA domain of HHR23A (green) (Protein Data Bank [PDB] code 1IFY [Mueller and Feigon, 2002] ), which is representative of the other UBA domains listed in Figure 6A .
In MARK2, the UBA domain binds to the N lobe of the catalytic domain close to the hinge, opposite to the cleft (i.e., at the ''back side''). The interaction is predominantly hydrophobic and mainly due to helix a3 (see Figures 6A and 6C) . At the catalytic domain, the interaction involves residues L115 and F116 at the beginning of b4. Other hydrophobic interactions involve residues at the N terminus of the N lobe (Y53) and at the b2-b3 turn; for example, L74 interacts with M335 and Y337 between helices a1 and a2 of the UBA domain which belong to the MGF/Y motif characteristic for UBA domains. In addition to the hydrophobic interactions, residue K105 at the end of helix C and the side chain amino group of K114 form hydrogen bonds to Y351 in the UBA domain.
Most UBA domains contain one or two leucines near the end of a3 (three in the case of MARK2, L359-L361). The first one (corresponding to L359) is highly conserved. It is important for the internal cohesion of the UBA domain by fitting into a hydrophobic pocket formed by residues of a1-a2 and the MGF/Y motif. In MARK2, the conserved L359 lies on the outside of the reversed helix a3 and makes hydrophobic contacts with the N lobe of the catalytic domain. Instead of L359, L361 forms hydrophobic intra-UBA interactions with side chains of helix a1 and the MGF/Y motif. The hydrophobic pocket normally occupied by the conserved leucine is narrowed by a w30º inward tilt of Y337. The remaining space is filled with the side chain of V354 at the start of a3 which-because of the inversion of the helix-ends up roughly at the same place as the conserved leucine in normal UBA structures.
In the position observed here, the UBA domain would not be able to interact with ubiquitin, judging by the published structures of mono-or polyubiquitin docked onto UBA domains of other proteins (Ohno et al., 2005; Varadan et al., 2005) . There would be a steric clash with the N lobe ( Figure 6D ). Consistent with this, attempts to identify a MARK2-ubiquitin complex biochemically have failed so far (data not shown).
UBA Linker and Common Docking Domain for Kinase Activators
The UBA domain is linked to the catalytic domain by w20 residues (w305-322; Figures 2 and 7) . The first half contains a motif similar to the common docking Ribbon diagram (stereoview) of the wild-type dimer viewed along the noncrystallographic 2-fold symmetry axis (molecule A, blue; B, purple). Residues involved in intermolecular contacts (at least one atom closer than 4 Å to an atom of the other molecule) are shown in stick model representation. Contact residues are color coded according to their distance from cyan (4 Å ) to red (w2 Å ). The shortest contact (2.07 Å distance) is between cysteines C210 in the double mutant (see Figure S2 ) which form an interchain disulfide bridge. No disulfide bridge is observed in the wild-type structure due to disorder. Most of the contact residues are in two zones: C-terminal anchor of the activation loop and the following loop preceding helix F (zone 1, residues 206-227) and helix G and part of its N-terminal loop (zone 2, residues 251-261). In the double mutant (not shown; see Figure S2) , zone 1 comprises 15 contact residues in the range from D207 to D227, zone 2 all but one residue in the range D251-R261. For the wild-type the corresponding numbers are lower (nine residues in zone 1, five residues in zone 2), due to disordered residues L206-C210. Residues S92, S93, and K96 at the N terminus of helix C form another cluster of contact residues (zone 3). Helix G and the preceding loop (zone 2) in one molecule insert into the space between zones 1 and 3 of the other molecule, making extensive contacts with both of these zones and approaching the RD motif (R174, D175) in the catalytic loop. Parts of the sequences determined by NMR or X-ray analysis are highlighted by gray and colored background (orange for helices a1, a2, and a3, pink for other helices; boundaries determined with PROMOTIF [Hutchinson and Thornton, 1996] ). Leading or trailing residues on white background were not part of the constructs. The parts enclosed by the black line correspond to the UBA domain identified by Prosite scans (Release 19.2 [Bucher and Bairoch, 1994] ). Residues at the C terminus of MARK2 are printed in purple to indicate that the structural alignment breaks down for this part of the sequence: starting with R350, the polypeptide chain diverges from the common trace of the other UBA structures, resulting in an orientation of the final helix that is reversed compared to normal UBA domains. Residues that have been shown to interact with ubiquitin are marked by blue underlines (for HHR23A, PDB code 1DVO; only residues of the primary interaction site are highlighted). In the case of MARK2, residues in contact with the N lobe of the kinase domain are marked. Columns: source, protein name, domain, Prosite score, PDB code. A plus sign following the Prosite score indicates that binding to ubiquitin has been reported. The list is sorted according to the Prosite score; sequences at the end of the list are not recognized as UBA domains (no score), although they are structurally similar. (B) Stereoview: overlay of the MARK2 UBA domain (yellow) with that of HHR23A (green) (PDB code 1IFY [Mueller and Feigon, 2002] ) after leastsquares superposition of nine residues in helix a1. Residues M335 and Y337 of the MGY motif are shown in stick model representation. Helix a2 of MARK2 is tilted outward by about 20º compared to HHR23A. This is accompanied by a change in the main chain conformation of the MGY loop motif (CD) of MAP kinases, characterized by a cluster of negative surface charges (DxxD/E; Tanoue et al., 2000) . In MARK2, the motif E 309 DDE 312 and surrounding residues fold into a loop similar to the common docking domain (CD domain) of MAP kinases (Figure 7) . Together with the ED site (corresponding to residues A185-D186 in MARK2) at the tip of the b7-b8 turn, the CD domain is thought to form a docking groove for upstream and downstream signaling molecules on the back surface of the catalytic domain opposite the active site (Tanoue and Nishida, 2003) , although the exact location of the docking groove is still a matter of debate (Chang et al., 2002) . The presence of these features in MARK2 suggests a similar function, but the putative docking partners are not known so far.
The second half of the stretch tethering the UBA and catalytic domain (''linker,'' w315-322) assumes an extended conformation. Remarkably, the linker has little contact to the lobes of the catalytic domain, and in fact L320 and adjacent residues are surrounded by interstitial water ( Figure 3B) . Accordingly, the B factors are high in this region (main chain B factor about 60), but the electron density was sufficiently well defined ( Figure 3B ) to trace the linker unambiguously all the way from the end of the catalytic domain up to the UBA domain. However, the loose attachment suggests the possibility that the linker and UBA domain could swing away from the catalytic domain and thus alter the regulatory state of the domains.
Discussion
MARK kinases constitute a subfamily of the AMPK/Snf1 family of kinases within the CAMK group of Ser/Thr kinases (Manning et al., 2002) . Apart from a highly conserved catalytic domain, the MARK kinases stand out in that they contain a C-terminal KA1 domain and a UBA domain adjacent to the catalytic domain (Figure 1 ). MARK occurs in four isoforms and several splicing variants. Here we present the structure of the MARK2 catalytic and UBA domain, including the connecting sequence of amino acids with a motif that may be involved in protein-protein recognition and regulation. By structural comparison of MARK2 with other kinases using the program CE (Shindyalov and Bourne, 1998) , Aurora-A and Aurora-B were consistently found at or close to the top of the ranking, even above CHK1, which is more closely related to MARK by sequence and which has been used for molecular replacement. The kinase domain of Aurora-A has been solved in an inactive form (in complex with adenosine; PDB code 1MUO [Cheetham et al., 2002] ), as well as in active and ''halfactivated'' forms (ATPgS complexes with/without a fragment of the activating protein TPX2; PDB codes 1OL5 and 1OL7, respectively [Bayliss et al., 2003] ) and, thus, lends itself as a paradigm for the discussion of the MARK2 structure.
Activation Segment
The inactive and the fully activated form of Aurora-A mainly differ by the conformation of the activation segment and by a 6.7º tilt of the minor lobe ( Figures 4B  and 4C ). In the inactive form, the activation loop is partially disordered; the N and C termini of the activation segment indicate that the activation loop points in a direction opposite to the active conformation (to the left side in Figure 4B ), passing close below the P-loop. In the MARK2 structures, only the C-terminal residues of the activation segment are visible. They adopt The structures of (A) MARK2 and (B) ERK2 (PDB code 2ERK [Canagarajah et al., 1997] ) are shown in the same orientations after leastsquares superposition of 35 residues from helix E to the catalytic loop. The common docking domain (CD, in red) according to Tanoue and Nishida (2003) is C terminal to the kinase domain and corresponds in MARK to the first half of the tether connecting the kinase domain to the UBA domain (residues w305-315). The C-terminal extensions following the CD domain (linker and UBA domain in MARK2) are shown in purple. Characteristic for the CD domain is a cluster of negatively charged residues exposed to the surface, located in a bulge at the end of the catalytic domain (stick model representation).
that translates into an w30º inward rotation of the aromatic ring of tyrosine Y337. At the end of helix a2 the peptide chains bend in different directions, in such a way that helix a3 ends up at almost the same position but with reversed orientation. (C) Stereoview: details of the binding interactions between the UBA domain and the N lobe of the catalytic domain of MARK2. All three leucines at the end of helix a3 are involved in hydrophobic interactions with the N lobe. The final leucine (L361) is also engaged in hydrophobic interactions with helix a1, and plays an important role for the cohesion of the UBA domain. In normal UBA structures, it is the almost invariant leucine (L359 in MARK) that is most important for the internal interactions. (D) Stereoview: UBA domain of MARK2 overlaid with that of Dsk2p in complex with ubiquitin. The UBA domains are green (Dsk2p, PDB code 1WR1 [Ohno et al., 2005] ) and purple (MARK2), ubiquitin is red, and the MARK2 kinase domain is yellow. In the overlay by least-squares fit of ten C a atoms of helices a1, the ubiquitin locates above the MARK2 kinase domain, with a small overlap in the b2-b3 region of the N lobe. a conformation similar to the inactive form of Aurora-A, suggesting that the activation loop of inactive MARK2 also folds to the left side ( Figure 4A ). By folding in this way, cysteine residues C210 of the two monomers can meet and form a disulfide bridge.
Superposition of MARK2 with the structure of the phosphorylated PKA in complex with peptides derived from protein kinase inhibitor PKI (Knighton et al., 1991; Madhusudan et al., 2002) reveals that the C-terminal part of the MARK2 activation loop occludes the space required for substrate binding. Thus, in the inactive state observed in the MARK2 structure, the substrate cannot bind in a productive way because of steric interference with the activation loop. Notably, threonine T208 (the primary phosphorylation site of the activation loop) is close to the position of the phosphorylation site (serine S21) of the peptide substrate in the PKA complex (C a distance 3.5 Å ), indicating the possibility of autophosphorylation. In phosphorylase kinase (PHK), another example of a kinase domain in complex with a substrate peptide (Lowe et al., 1997) , the substrate binds in an extended conformation analogous to the PKA-PKI complex. As in the case of PKA, binding of the substrate to MARK2 in the same position as in PHK would result in a steric clash with residues 208 to 210-at least according to the double mutant, where these residues are stabilized by the disulfide bridge between cysteines C210.
Catalytic Cleft and Nucleotide Binding Site
The catalytic cleft in the MARK2 structure is extremely wide open, compared to other active or inactive kinases. It is 1-2 Å wider than the cleft of Aurora-A in the inactive form, judged by the distance between b1 (N lobe) and b6 (C lobe). In the activated form of Aurora-A, as in other active kinases, helix C of the N lobe contributes to nucleotide binding by a conserved glutamic acid (E100 in MARK2) that forms a salt bridge with a strictly conserved lysine in strand b3 (K82 in MARK2; Figure 4F ) and positions this lysine for proper coordination of the nucleotide's a-and b-phosphates. In the crystal structure of the MARK2 double mutant, the side chains of K82 and E100 are not aligned correctly for interaction with the nucleotide (Figure 4D ). In the wild-type structure and especially in that of the K82R mutant, the side chains of K82 and E100 are less well ordered (by B factor) or even invisible. It is not surprising that long side chains facing the activation loop are affected by disorder. This applies also to methionine M104, which reveals a double conformation that could be identified due to the high electron density of the selenium atom in the SeMet structure. There is no hint at a specific interaction between K82 and E100 in any of the four MARK2 structures.
Conformation of the Catalytic Loop
Activation of Aurora-A involves phosphorylation of threonines T287 and T288 in the activation loop. In the fully activated state, the phospho group of pT288 (primary phosphorylation site, corresponding to T208 in MARK2) is engaged in ion pair interactions with R255 in the catalytic loop (R174 in MARK2), adjacent to the catalytically active aspartate D256 (D175 in MARK2; Figure 4F ). This interaction stabilizes the catalytic loop and positions the aspartate toward the attacking OH group of the substrate. In MARK2, the overall fold and conformation of the catalytic loop is the same; there are, however, significant differences that culminate at the RD motif (R174 and D175; Figures 4D-4F ): the side chain of D175 is too far from N180 further down the catalytic loop to form a hydrogen bond, which is important for coordination of a divalent cation. The absence of the hydrogen bond between D175 and N180 is probably a consequence of the unusual main chain conformation of the RD motif. Possibly the catalytic loop adopts several slightly different conformations which cannot be described adequately by a single conformation. This would agree with the assumption that the catalytic loop needs stabilization by interaction with the primary phospho site. The unusual conformation of the RD motif in MARK2 could also be induced by interaction of the two monomers of the dimer: helix G of one molecule protrudes toward the catalytic loop of the other molecule, with the side chain of N254 at the tip of helix G approaching the catalytic aspartate (minimum distance 3.3 Å ; Figure 5 ).
C-Terminal Extension, UBA Domain, and Regulation of MARK2
Many kinases comprise C-terminal extensions of the catalytic core that wrap around the core domain and terminate in a subdomain that binds to the N lobe. They are probably involved in regulation of kinase activity, comparable to regulatory proteins of other kinases, like cyclins for CDKs or TPX2 and INCENP in the case of Aurora-A and -B, respectively. In PKA, for instance, the C-terminal extension spirals up in a right-handed rotation, and in the MAP kinases ERK2 and p38 it winds in the opposite direction around the core domain; in either case, the terminal subdomain ends up at a similar location, close to helix C of the N lobe.
In MARK2, a corresponding extension consists of the UBA domain which is linked to the catalytic domain by a sequence of about 20 amino acids, comprising a bulge with a cluster of negatively charged residues (wN305-P315) and a straight section heading for the UBA domain (linker, wP315-D322) . This is roughly similar to ERK2 except that the UBA domain binds at some distance to helix C (Figure 7) . In MAP kinases, the bulge residues (wL311-P321 in ERK2 and wF308-P318 in p38) have been proposed as a CD domain for many upstream and downstream interaction partners (Tanoue et al., 2000; Tanoue and Nishida, 2003) . The similarity in position, conformation, and amino acid composition suggests that the bulge in the structure of MARK2 may also play a role in protein-protein recognition.
The UBA domain is linked to the potential CD domain by a stretch of about seven residues in extended conformation. As the UBA domain binds opposite to the catalytic cleft, at the back of the hinge region, closure of the catalytic cleft by rotation of the N lobe (with the UBA domain attached on it) around the hinge would require further elongation of the linker (e.g., by unfolding of the CD domain) or detachment of the UBA domain from the N lobe. Thus, it seems that the crystal structure of MARK2 represents a state with the kinase domain locked in an open (inactive) conformation. A similar mechanism for regulation of kinase activity has been proposed for Aurora-B (Sessa et al., 2005) . In the crystal structure of Aurora-B with part of the activating protein INCENP, the C-terminal tail of the kinase domain assumes an extended conformation and connects back to the N lobe, similar to MARK2. In the case of Aurora-B, the contact to the N lobe is mediated by INCENP, in the case of MARK2 by the UBA domain. The INCENP peptide consists of three helices that wind around the N lobe. Interestingly, the second helix (B) binds to the same groove at the surface of the N lobe as the UBA domain. Thus, in a superposition of the structures, helix B of INCENP and helix a3 of the UBA domain would overlap to a large extent.
The role of the UBA domain in MARKs is unknown, but its presence is suggestive of a ubiquitin-related function, such as protein degradation or others (Buchberger, 2002) . Other possibilities include an autoregulatory role, reminiscent of Ca/calmodulin-regulated kinases whose C-terminal tail binds into the catalytic cleft, or members of the PAK or MAP kinase families which have extra helices that bind to the N lobe. Superposition of the MARK2-UBA structure with published UBA-ubiquitin complexes ( Figure 6D ; Ohno et al., 2005; Varadan et al., 2005) shows an overlap between the catalytic domain and ubiquitin, indicating that binding of the two would be mutually exclusive.
While the MARK sequence complies with the Prosite profile of the UBA domain ( Figure 6A ; Hofmann and Bucher, 1996) , the crystal structure reveals an unexpected conformation as the third helix is inverted compared to the known structures. It is conceivable that the inversion of helix a3 is evoked by interaction with the N lobe, whereas the free UBA domain (after detachment from the catalytic domain) could adopt the normal conformation. Alternatively, the unusual conformation of the UBA domain could be a specific feature of MARK2 and related kinases. We note that the structures of UBA domains vary considerably, complementary to the variable interactions with mono-or polyubiquitin, and the different linkage modes of polyubiquitin (Chim et al., 2004) . This opens a range of potential regulatory interactions which awaits further analysis.
Experimental Procedures
Protein Preparation, Labeling, and Crystallization Fragments of MARK2 from rat (GenBank accession number CAB06295 [Drewes et al., 1997] ) were cloned and expressed in E. coli strain BL21 AI (Invitrogen, Karlsruhe, Germany) by using the manufacturer's protocol. The MARK2 fragment N39-K364 described here was identified by limited proteolysis, and it is identical in sequence to human MARK2. The construct includes an N-terminal glycine (G38) left over from TEV protease cleavage of a His 6 tag. All point mutations (T208A/S212A, K82R) were subcloned from existing plasmids and the proteins were purified as described (Timm et al., 2003) . Selenomethionine labeling was done by expression in methionine auxotrophic E. coli strain B834 (Invitrogen) using M9 minimal medium supplemented with all amino acids except methionine, and 40 mg SeMet (Arcos Organics, Geel, Belgium) per liter. Crystals were grown by vapor diffusion by mixing 2 ml of protein (20 mg/ml) with 2 ml of a reservoir solution containing 7%-10% PEG 3350, 0.1 M Bis-Tris (pH 6.5), 0.2 M ammonium sulfate, or 7%-10% PEGMME 5000, 0.1 M Bis-Tris (pH 6.5), 7.5% tacsimate at room temperature. Heavy-atom derivatives were obtained by soaking in 1 mM KAuCl 4 or Yb(NO 3 ) 3 . The kinase activities of the MARK2 constructs were assayed as described (Drewes et al., 1997) using a substrate peptide from the first repeat of tau containing S262 in the KXGS motif (TR1 peptide NVKSKIGSTENLK).
Data Collection, Phasing, and Model Building X-ray data were obtained at the synchrotron beamline of the X13 Consortium at DESY (Deutsches Elektronen-Synchrotron), Hamburg. Crystals were flash frozen and kept at 100 K in cold nitrogen. Data reduction, statistical analysis, phasing, and refinement were performed using programs of the HKL data processing system V1.97.2 (Otwinowski and Minor, 1997) and the CCP4 program package (CCP4, 1994). All crystals had a similar shape (short hexagonal rods) and belonged to space group P6 1 ; they fall, however, into two distinct classes differing by the length of the c axis (see Table  1 ). The double mutant consistently crystallized in the form with the longer c axis, whereas the wild-type crystallized in both forms, with a preference for the shorter c axis.
A potential molecular replacement (MR) solution was obtained with the checkpoint kinase CHK1 as a search model (PDB code 1IA8 [Chen et al., 2000] ), using the program PHASER, version 1.2 (Storoni et al., 2004) , which found two molecules in the asymmetric unit. The solution was confirmed by its ability to identify heavy-atom sites in weak Au and Yb derivatives using phases calculated from the MR solution. Heavy-atom parameters were refined and experimental phases were calculated with MLPHARE, including the anomalous signals of both derivatives. Occupancies of the heavy atoms ranged between 0.27 and 0.40. Experimental phases from MLPHARE were improved with DM by solvent flattening, histogram mapping, and NCS averaging. The overall mean figure of merit after phase extension to 2.7 Å with DM was 0.79. Several rounds of manual model building using O (Jones et al., 1991) , local real space refinement with RSRef2000 (Korostelev et al., 2002) , and phase combination of model and experimental phases were followed by automatic refinement with CNS 1.1 (Brunger et al., 1998) for simulated annealing, switching to REFMAC5 (Murshudov et al., 1997) at later stages of refinement. At that time, higher quality crystals of the SeMet derivative became available. This SeMet derivative was the first of four MARK2 structures to be refined to the end, using the partially refined model of the double mutant as start model. The final R factor was 0.198 (R free = 0.268) using all reflections up to 2.5 Å (mean I/s(I) > 2). Structures of the double mutant with native methionine, wild-type, and the K82R mutant were modeled after the SeMet derivative using the same subset of reflections for cross-validation. The quality of the models was checked with the programs PROCHECK (Laskowski et al., 1993) and WHAT_CHECK (Hooft et al., 1996) using DSSP secondary structure assignments (Kabsch and Sander, 1983) .
Supplemental Data
Supplemental Data include details of experimental procedures, crystal packing, and intermolecular contacts and can be found with this article online at http://www.structure.org/cgi/content/full/ 14/2/173/DC1/.
